Results 111 to 120 of about 3,260 (145)

Successful Treatment of Evans Syndrome Onset With Zanubrutinib in Combination With Romiplostim During Venetoclax Treatment in a Patient With Chronic Lymphocytic Leukemia: A Case Report. [PDF]

Clin Case Rep
Innao V, Barbagallo APM, Bianco O, Leotta V, Consoli U.   +4 more
europepmc   +1 more source

Where next for BTKi-BCL2i combinations in mantle cell lymphoma? [PDF]

Br J Haematol
Eyre TA.
europepmc   +1 more source

Cardiovascular Toxicity of BTK Inhibitors: A Patient-Centered Framework for Risk Stratification and Management. [PDF]

J Clin Med
Tedeschi A, Barocelli F, Gerra L, Breviario F, Sbarra F, Pagnoni G, Marasacchia G, Marangi F, Darroudi S, Di Spigno F, Coppi F, Arcari A, Losi G, Vallisa D, Niccoli G, Aschieri D, Navazio A, Tarantini L.   +17 more
europepmc   +1 more source

Case Report: Occult mantle cell lymphoma in a synchronous rectal collision tumor with adenocarcinoma: retrospective reclassification and multispecimen molecular profiling. [PDF]

Front Oncol
Zhang Q, Xiu Y, Li J, Cao X.
europepmc   +1 more source

An indirect comparison of zanubrutinib vs acalabrutinib plus venetoclax in patients with treatment-naive CLL. [PDF]

Blood Adv
Shadman M, Tam CS, Brander DM, Lefebure M, Yang K, Xu S, Tian T, Kuptsova-Clarkson N, Williams R, Hirata J, Munir T.   +10 more
europepmc   +1 more source

Physiologically Based Pharmacokinetic Modeling to Assess Antiretroviral-BTK Inhibitor Interactions and Provide Recommendations for Co-Administration Regimens. [PDF]

Pharmaceutics
Chen L, Wang X, Li L, Yang Y, Liu Y, Chen W.   +5 more
europepmc   +1 more source

Real-world effectiveness of zanubrutinib plus salvage chemotherapy in relapsed or refractory double-expressor DLBCL. [PDF]

Ann Hematol
Lu J, Zhang Y, Ye X, Shi J, Lin Q, Li R, Du X, Cao L, Tian T, Wang J, Xia Y, Liu H, Cheng Y, Fan L, Shen H, Wang S.   +15 more
europepmc   +1 more source

Pooled safety analysis of zanubrutinib monotherapy in Asian patients with B-cell malignancies. [PDF]

ESMO Open
Zhu J, Li J, Tam CS, Wang L, Xu J, Zhang J, Khanna P, Qiu L.   +7 more
europepmc   +1 more source

Zanubrutinib combined with R-CHOP in previously untreated diffuse large B-cell lymphoma with specific gene alteration: a phase II study. [PDF]

Blood Cancer J
Zhang Q, Jiang S, Wei R, Zhang W, Bao L, Liu Y, Jin J, Lv F, Liu C, Liu X, Sun H, Wang J, Tao R, Zhou X, Cao J.   +14 more
europepmc   +1 more source

Cardiovascular Toxicity of BTKi in Chronic B-Cell Malignancies. [PDF]

Rev Cardiovasc Med
Gan H, Lin J, Sun Q, Xu J, He Q, Chen S, Feng Y, Hu B, Wang W.   +8 more
europepmc   +1 more source